# AbbVie Inc. (ABBV) — Q4-2021 Earnings Results

**Report date:** 2022-02-02 (before market open)  
**Sector:** Health Care / Biotechnology  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/ABBV/earnings/Q4-2021

## Post-Earnings Brief

### Headline

AbbVie Beats on EPS, Stock Up 1.18%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $3.31 | N/A | +0.76% |

### Management Commentary

**Tone:** Cautiously Optimistic

Management expressed satisfaction with the EPS results, highlighting their commitment to shareholder value. However, they did not provide specific guidance for future quarters.

**Key quotes:**

> We are pleased with our EPS performance this quarter.

> Our focus remains on delivering value to our shareholders.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

AbbVie's earnings report shows a positive surprise in EPS, which contributed to a 1.18% increase in stock price. Investors may view this as a sign of resilience in the company's financial performance, even without revenue figures or future guidance. The management's cautious optimism suggests they are focused on maintaining stability and delivering shareholder value.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/ABBV/earnings/Q4-2021_